FDA Introduces Postmarket Review for 10000 Food Chemicals to Boost Safety
The FDA has launched a new initiative to systematically review 10,000 food chemicals currently used in the U.S. food supply, aiming to improve transparency and safety. This marks a shift from the previous reactive approach, where chemicals were reviewed only after public petitions or emerging scientific concerns.
FDA Commissioner Martin A. Makary stated that the agency is leveraging "gold standard science" to prioritize chemicals that raise consumer concerns, such as BHA, BHT, and azodicarbonamide, which are commonly used in processed foods. These chemicals have been linked to cancer and hormone disruption in studies.
The agency plans to release a draft framework for its new review process, inviting public feedback before finalization. Expedited evaluations are also planned for controversial additives, including phthalates, propylparaben, and titanium dioxide, to address potential health risks more quickly.
Health officials, including HHS Secretary Robert F. Kennedy Jr., emphasized the urgency of addressing chronic diseases linked to additives and ultraprocessed foods, calling this a critical step toward ensuring a safer food supply.
While the new framework is expected to enhance consumer trust, the FDA faces challenges, including recent layoffs that may limit its capacity. To address this, the agency is hiring external contractors to support its efforts.
This initiative is a major reform in food safety regulation, with the potential to revoke approvals for harmful chemicals or introduce stricter labeling requirements, ultimately encouraging companies to reformulate their products.
2026-10-18
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
FDA Fee Updates Raise the Cost of Entering the U.S. Generic Drug Chain
-
FDA Dye Pledges Push Natural Colors Into the Mainstream
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
Trump Urges Ukraine to Halt Russian Refinery Strikes as Diesel Shortage Becomes a Global Policy Issue
-
关于全面排查下架易制毒及易制爆产品信息的公告 Announcement on the Comprehensive Review and Removal of Product Information Related to Precursor and Explosive Precursor Chemicals
-
U.S. and China Reach Consensus on More Favorable Tariff Treatment for $30 Billion of Goods Each Way
-
U.S. Section 232 Pharmaceutical Tariffs Take Effect, With 100% Base Rate on Patented Drugs and APIs
-
3M, DuPont and Honeywell Must Face Firefighters’ PFAS Turnout-Gear Lawsuit
-
EAEU Initiates Review of Anti-Dumping Measures on Chinese Titanium Dioxide, Suspends Duties During Investigation
-
UK Opens Formal Review of AkzoNobel–Axalta $25 Billion Merger
Recommend Reading
-
India Proposes New GMP Rules for Clinical Trial and API Manufacturing
-
Colombia Makes Preliminary Ruling in Anti-Dumping Investigation into Chinese DOP Imports
-
Pakistan Launches Successive Anti-dumping Investigations against Chinese Products, Involving Soda Ash, Ibuprofen and Other Raw Materials
-
Four Fine Chemical Units of Huajin Aramco Project – HDPE, EO/EG, etc. – Reach Mechanical Completion
-
关于将二氟乙咪酯等16种物质列入《非药用类麻醉药品和精神药品目录》的公告 Announcement on the Inclusion of 16 Substances including Difluoroetomidate in the Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances
-
Inventory Accumulation Expectations Remain, PTA Prices Continue to Fluctuate and Weaken
-
2026 Mid-Autumn Festival & National Day Holiday Notice
-
Premium Global Chemical Sourcing Requests (21-23Sep.,2026)
-
Phosphoric Acid: Uses in Cola, Rust Removal, and Fertilizers Explained
-
Silver Nitrate: Medical Uses, Photography History, and Staining Properties